Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director Director departure
|
CV Sciences, Inc. (CVSI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/14/2023 |
8-K
| Quarterly results |
06/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/15/2023 |
8-K
| Quarterly results |
03/29/2023 |
8-K
| Quarterly results |
03/17/2023 |
4
| Dowling Joseph D (CEO) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Granted 2,500,000 options to buy
@ $0.04, valued at
$100k
|
|
03/17/2023 |
4
| Grasser Joerg (CFO) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Granted 1,250,000 options to buy
@ $0.04, valued at
$50k
|
|
03/02/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/14/2022 |
8-K
| Quarterly results |
11/07/2022 |
4
| McCorkle William (Director) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Granted 500,000 options to buy
@ $0.04, valued at
$20k
|
|
11/07/2022 |
3
| McCorkle William (Director) has filed a Form 3 on CV Sciences, Inc. |
10/25/2022 |
8-K
| Quarterly results |
09/27/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
08/15/2022 |
4
| Corroon James Michael Jr. (Director) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Granted 500,000 options to buy
@ $0.0325, valued at
$16.3k
|
|
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/15/2022 |
8-K
| Quarterly results |
07/29/2022 |
3
| Corroon James Michael Jr. (Director) has filed a Form 3 on CV Sciences, Inc. |
07/27/2022 |
8-K
| Resignation/termination of a director |
06/06/2022 |
8-K
| Quarterly results |
06/01/2022 |
8-K
| Quarterly results |
05/24/2022 |
8-K
| Quarterly results |
05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/16/2022 |
8-K
| Quarterly results |
04/15/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/04/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
04/01/2022 |
4
| Grasser Joerg (CFO) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Disposed/sold 750,000 options to buy
@ $0.59, valued at
$442.5k
Disposed/sold 750,000 options to buy
@ $0.33, valued at
$247.5k
Disposed/sold 250,000 options to buy
@ $0.66, valued at
$165k
|
|
04/01/2022 |
4
| Dowling Joseph D (CEO) has filed a Form 4 on CV Sciences, Inc.
Txns:
| Disposed/sold 1,500,000 options to buy
@ $0.33, valued at
$495k
Disposed/sold 1,500,000 options to buy
@ $0.59, valued at
$885k
Disposed/sold 500,000 options to buy
@ $0.66, valued at
$330k
Disposed/sold 500,000 options to buy
@ $0.4, valued at
$200k
Disposed/sold 100,000 options to buy
@ $0.38, valued at
$38k
Disposed/sold 200,000 options to buy
@ $0.73, valued at
$146k
Disposed/sold 600,000 options to buy
@ $0.38, valued at
$228k
Disposed/sold 1,000,000 options to buy
@ $0.368, valued at
$368k
Disposed/sold 1,000,000 options to buy
@ $0.365, valued at
$365k
|
|
03/31/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
03/31/2022 |
8-K
| Quarterly results |
03/28/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/28/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
12/21/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/01/2021 |
8-K/A
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
|
|
|